
Friday, July 07, 2006 8:26:02 AM
Recent CAPC News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2025 07:36:16 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/08/2025 08:45:56 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/26/2025 10:59:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2025 04:50:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2025 09:21:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/14/2025 12:45:43 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/10/2025 07:02:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2025 03:16:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2025 01:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/14/2025 02:00:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2025 02:47:18 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/08/2025 02:46:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2025 09:09:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 12/26/2024 10:02:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2024 07:15:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 10:00:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 06:43:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2024 07:10:54 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM